Related Experiment Video
Updated: May 30, 2025

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
Published on: June 15, 2012
High-Viability Circulating Tumor Cells Sorting From Whole Blood at Single Cell Level Using Laser-Induced Forward
Qingmei Xu1,2, Yuntong Wang3,4, Songtao Dou1
1School of Integrated Circuits, Peking University, Beijing, 100871, China.
This study introduces a novel system for isolating circulating tumor cells (CTCs) with high viability for molecular analysis. The laser-induced forward transfer-assisted microfiltration system (LIFT-AMFS) enables efficient CTC retrieval for personalized cancer treatments.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Oncology
Background:
- Efficient isolation of circulating tumor cells (CTCs) is vital for cancer metastasis research and personalized medicine.
- Cell viability is critical for downstream molecular analyses like RNA sequencing.
- Existing methods face challenges in achieving high-viability CTC isolation at single-cell resolution.
Purpose of the Study:
- To develop and validate a novel system for high-viability CTC enrichment and retrieval from whole blood.
- To enable downstream molecular analyses, including RNA sequencing, on isolated single CTCs.
- To improve the efficiency and throughput of CTC isolation for clinical applications.
Main Methods:
- Development of a laser-induced forward transfer-assisted microfiltration system (LIFT-AMFS).
- Utilized a LIFT-compatible double-stepped microfilter (DSMF) for size-based cell separation and liquid encapsulation.
- Optimized DSMF design for enhanced capture efficiency and single-cell retrieval.
Main Results:
- Achieved 88% CTC capture efficiency at a throughput of 15.0 mL/min.
- Obtained over 95% single-cell yield during the retrieval stage with high cell viability.
- Isolated CTCs yielded sufficient cDNA (>4.5 ng) for library construction, with Q30 scores >95.92% for single-cell sequencing.
Conclusions:
- The LIFT-AMFS effectively enriches and retrieves high-viability CTCs from whole blood.
- The system supports downstream molecular analyses, including ex vivo culture and RNA sequencing.
- LIFT-AMFS demonstrates significant potential for advancing cellular and biomedical research in oncology.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019